Food and Drug Administration Panel Rejects ‘Bionic Eye’ for Citing Safety
Food and Drug Administration panel rejects Implantable Miniature Telescope designed to be implanted in the eyes of some elderly patients by 10-3 vote.
According to a new study, the device, which contains two lenses that work with the cornea to create a magnified image could enable some patients to do away with the special glasses and handheld telescopes, they now use to compensate for the loss in central vision caused by age-related macular degeneration.
The FDA's ophthalmic devices panel recommended against the pea-sized bionic device for safety reasons, spokeswoman Heidi Valetkevitch said
The device is designed to be implanted only in one eye, which would provide central vision. The other eye, left untouched, would be responsible for peripheral vision, leaving the brain to combine the two views to form a single image. Getting used to that could require patients to undergo professional rehabilitation, the FDA said.
Filed under Eye Treatment
You may also like to read
- Does LASIK Improves Patients Lives? - FDA Review
- FDA Proposes Improving Contact Lens Product Testing and Advocating Universal Lens-care Guidelines
- FDA To Review US Contact Lens Cleaners After Fusarium Keratitis & Acanthamoeba Parasite Infections
- Combination Antibiotic-Steroid for Ocular Inflammation Filed for FDA Approval
- Lucentis - Wet Macular Degeneration Drug is Highly Successful in Clinical Trials
- Diabetes Drug Avandia Causing Macular Edema
- Can-Fite Begins Phase II Trials for Treatment of Symptoms of Keratitis Sicca (Dry-Eye Syndrome)
- Alcon Gets FDA Approval for Travatan-Z Which Reduce Elevated Intraocular Pressure
- STAAR Seeks FDA Approval of Visian TICL Implantable Contact Lens For Nearsightedness and Astigmatism Treatment
- Bausch & Lomb Urging Soft Contact-Lens Wearers To Stop Using ReNu
